Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 13, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,082	650	763	756	572	993
Market Cap Growth	85.40%	-14.84%	0.93%	32.18%	-42.41%	-10.20%
Enterprise Value	1,047	608	728	702	554	963
Last Close Price	15.42	10.06	11.43	11.03	8.94	15.20
PE Ratio	2833.20	-	-	55.27	35.75	26.30
PS Ratio	2.99	2.19	3.11	3.68	2.88	4.68
PB Ratio	4.09	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	8.34	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	20.53	-	-	35.85	21.10	12.57
P/OCF Ratio	20.29	-	-	33.66	15.11	11.87
EV/Sales Ratio	2.89	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	21.84	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	25.25	-	-	67.70	23.07	12.62
EV/FCF Ratio	19.85	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.50	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	2.55	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	2.48	-	-	7.91	5.97	2.05
Asset Turnover	0.81	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.57	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.39	2.96	3.28	3.90	4.69	3.09
Current Ratio	3.16	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	0.03%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	5.76%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Invested Capital (ROIC)	0.08%	-2.10%	-12.76%	5.79%	10.98%	54.07%
Return on Capital Employed (ROCE)	10.70%	-1.10%	-5.70%	2.80%	6.80%	22.30%
Earnings Yield	0.04%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	4.87%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	2.65%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q